Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Award
Common Stock
2025-02-04+14,624→ 64,315 total - Award
Common Stock
2025-02-04+8,448→ 72,763 total
Holdings
- 140(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025.
- [F2]Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025.